FDA recalls two lots of Adequan Canine arthritis injections nationwide

Adequan Canine recall label on a vial of the prescription arthritis medication for dogs.

Dog owners are being urged to check their pet’s arthritis medication after a nationwide recall was issued for two lots of Adequan Canine Injection because of the potential presence of glass fibers.

American Regent Inc. Animal Health announced the recall after glass fibers were found during testing of internally retained samples of the prescription medication, according to a notice published by the U.S. Food and Drug Administration.

Adequan Canine is a prescription injectable medication used to treat noninfectious degenerative or traumatic joint dysfunction in dogs. The drug is administered by or under the direction of a licensed veterinarian, though some pet owners administer the injections at home after receiving instruction from their veterinarian.

According to the recall notice, injecting a product containing particulate matter such as glass fibers could cause local irritation, swelling, inflammation, injection-site pain, infection or abscesses. The company said it has not received any reports of adverse events related to the recalled lots.

The recall affects the following lots of Adequan Canine Injection (100 mg/mL, 5 mL multi-dose vial):

  • Lot 3369, distributed beginning May 22, 2024, with an expiration date of Oct. 31, 2026
  • Lot 25011, distributed beginning April 14, 2025, with an expiration date of Dec. 31, 2027.

The affected products were distributed nationwide to online pharmacies, distributors, wholesalers and veterinary clinics. The recall is being conducted to the consumer level, meaning pet owners who have the affected medication should stop using it immediately.

Owners who believe that they may have one of the recalled lots should contact their veterinarian for guidance. The company also advises pet owners to contact their veterinarian if their dog has experienced any problems that may be related to the medication.

Veterinary clinics, distributors and retailers have also been instructed to stop distributing the affected products and either return any unused medication to the manufacturer or discard it.

Leave a Comment

Your email address will not be published. Required fields are marked *

Scroll to Top